ZA200309770B - A method of diagnosing or prognosticating major respiratory bacterial pathogens in a subject. - Google Patents

A method of diagnosing or prognosticating major respiratory bacterial pathogens in a subject.

Info

Publication number
ZA200309770B
ZA200309770B ZA200309770A ZA200309770A ZA200309770B ZA 200309770 B ZA200309770 B ZA 200309770B ZA 200309770 A ZA200309770 A ZA 200309770A ZA 200309770 A ZA200309770 A ZA 200309770A ZA 200309770 B ZA200309770 B ZA 200309770B
Authority
ZA
South Africa
Prior art keywords
subject
prognosticating
diagnosing
bacterial pathogens
iii
Prior art date
Application number
ZA200309770A
Other languages
English (en)
Inventor
Jesper Eugen-Olsen
Original Assignee
Virogates Aps
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virogates Aps filed Critical Virogates Aps
Publication of ZA200309770B publication Critical patent/ZA200309770B/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56944—Streptococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ZA200309770A 2001-05-18 2003-12-17 A method of diagnosing or prognosticating major respiratory bacterial pathogens in a subject. ZA200309770B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200100799 2001-05-18

Publications (1)

Publication Number Publication Date
ZA200309770B true ZA200309770B (en) 2004-09-28

Family

ID=8160511

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200309770A ZA200309770B (en) 2001-05-18 2003-12-17 A method of diagnosing or prognosticating major respiratory bacterial pathogens in a subject.

Country Status (11)

Country Link
US (1) US7399602B2 (xx)
EP (1) EP1405076B1 (xx)
CN (1) CN100340858C (xx)
AT (1) ATE479097T1 (xx)
BR (1) BRPI0210903B8 (xx)
DE (1) DE60237448D1 (xx)
DK (1) DK1405076T3 (xx)
EA (1) EA005776B1 (xx)
ES (1) ES2351690T3 (xx)
WO (1) WO2002095411A1 (xx)
ZA (1) ZA200309770B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2291226T3 (es) 1999-11-25 2008-03-01 Jesper Eugen-Olsen Un metodo de diagnostico o prognosis de infeccion por vih en un sujeto.
US20060084184A1 (en) * 2004-10-19 2006-04-20 Renovar Incorporated Reagents for urine-based immunological assays
JP4943515B2 (ja) * 2007-12-28 2012-05-30 株式会社ビーエル 結核菌群の免疫検出法
AU2012256683B2 (en) * 2011-05-19 2017-02-02 Mochida Pharmaceutical Co., Ltd. Diagnosis of respiratory tract infectious diseases using urine specimens
GB201211982D0 (en) * 2012-07-05 2012-08-22 Isis Innovation Biomarker
WO2015159239A1 (en) * 2014-04-15 2015-10-22 Stellenbosch University A method for diagnosing tuberculous meningitis
US10094833B2 (en) 2014-08-08 2018-10-09 Randox Laboratories Limited Method and kit for detecting bacterial infection
CN106556703A (zh) * 2016-10-18 2017-04-05 上海凯璟生物科技有限公司 一种慢性肾脏病标志物suPAR检测试剂盒和制备方法
RU2659384C1 (ru) * 2017-07-10 2018-06-29 Федеральное государственное бюджетное учреждение "Детский научно-клинический центр инфекционных болезней Федерального медико-биологического агентства" Способ раннего прогнозирования характера течения острой респираторной инфекции у детей
GB201802795D0 (en) * 2018-02-21 2018-04-04 Virogates As Patient assessment method
FR3080185A1 (fr) * 2018-04-16 2019-10-18 Biomerieux Evaluation du risque de complication chez un patient suspecte d'avoir une infection ayant un score sofa inferieur a deux
US20230236196A1 (en) * 2020-04-08 2023-07-27 Virogates A/S Sars-cov-2 infection risk assessment method
RU2765744C2 (ru) * 2020-07-20 2022-02-02 Федеральное государственное бюджетное образовательное учреждение высшего образования "Кировский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Кировский ГМУ Минздрава России) Способ определения вероятности летального исхода на основании жалоб у больного туберкулезом с ВИЧ-инфекцией при поступлении в стационар Федеральной службы исполнения наказаний РФ
CN113295874B (zh) * 2021-05-25 2022-03-04 广东源心再生医学有限公司 一种用于瓣膜性心脏病辅助诊断的新型标志物、辅助诊断的产品

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4845026A (en) * 1985-12-03 1989-07-04 T Cell Sciences, Inc. Assay systems for detecting cell-free T cell antigen receptor related molecules and the clinical utilities of the assays
US5459078A (en) * 1988-01-29 1995-10-17 Abbott Laboratories Methods and reagents for performing ion-capture digoxin assays
IL137454A0 (en) 1998-01-26 2001-07-24 Biotech Australia Pty Ltd PAI-2 AND t-PA AS DIAGNOSTIC MARKERS OF PERIODONTAL DISEASE
US6077508A (en) * 1998-03-23 2000-06-20 American Diagnostica Inc. Urokinase plasminogen activator receptor as a target for diagnosis of metastases
DE19840671A1 (de) 1998-08-26 2000-03-02 Stiftung Tumorbank Basel Verfahren zur Diagnose von Rezidiven bei nodal-negativem Brustkrebs
WO2000065349A2 (en) 1999-04-28 2000-11-02 Cardiogenics Inc. Method for determining plasminogen activator inhibitor
ES2291226T3 (es) 1999-11-25 2008-03-01 Jesper Eugen-Olsen Un metodo de diagnostico o prognosis de infeccion por vih en un sujeto.

Also Published As

Publication number Publication date
BRPI0210903B8 (pt) 2021-07-27
EP1405076A1 (en) 2004-04-07
DE60237448D1 (de) 2010-10-07
EA200301271A1 (ru) 2004-06-24
BR0210903A (pt) 2004-06-08
US20050100961A1 (en) 2005-05-12
WO2002095411A1 (en) 2002-11-28
BRPI0210903B1 (pt) 2017-01-17
EA005776B1 (ru) 2005-06-30
ES2351690T3 (es) 2011-02-09
ATE479097T1 (de) 2010-09-15
US7399602B2 (en) 2008-07-15
CN100340858C (zh) 2007-10-03
DK1405076T3 (da) 2011-01-03
CN1723394A (zh) 2006-01-18
EP1405076B1 (en) 2010-08-25

Similar Documents

Publication Publication Date Title
ZA200309770B (en) A method of diagnosing or prognosticating major respiratory bacterial pathogens in a subject.
GB2461410A (en) Soluble urokinase plasminogen activator receptor (SUPAR) as marker for diseases
IS7286A (is) Aðferðir til þess að mæla hæfi glatiramerasetats
MXPA03003281A (es) Deteccion enzimatica no invasiva de estados asociados con la remodelacion de tejidos.
AU2003220970A1 (en) Diamino-pyrimidines and their use as angiogenesis inhibitors
AP1623A (en) A method of diagnosing of prognosticating HIV infection in a subject.
WO2000062070A3 (en) Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker
SE0100195L (sv) Utvärderingsförfaranden för antitumöraktivitet
WO2002036197A3 (en) Method and system for measuring a source impedance of at least one cardiac electrical signal in a mammalian heart
DE3751224T2 (de) Diagnostischer test für plasminogenaktivatoren vom gewebs- und urokinasetyp und dafür kodierende gene.
BRPI0410467A (pt) composições e métodos para tratamento de sìndrome respiratória aguda severa (sars)
HK1059038A1 (en) Method of examining effect of angionegesis inhibitor mediated by the inhibition of integrin expression
SE0004872D0 (sv) Method for detoxifying a medical solution
WO2003023056A3 (en) Specific markers for multiple sclerosis
NO20003766L (no) PAI-2 og t-PA som diagnostiske markører for periodontal sykdom
PL1680667T3 (pl) Sposób i urządzenie do ultradźwiękowego badania obiektu
WO2005087917A8 (en) Enzyme and preparation method
WO2000065349A3 (en) Method for determining plasminogen activator inhibitor
WO2002056666A3 (en) A method of detecting ultrasound contrast agent in soft tissue, and quantitating blood perfusion through regions of tissue
EP0276328A4 (en) Process for separating the human single-strand tPA from the human double-strand tPA.
AU9397101A (en) Apparatus and method for measurement of biological structures
WO2005058373A3 (en) Methods, program products, and systems for single and multi-agent dosing
WO2001042488A3 (en) Plasminogen activator assay involving an elastase inhibitor
DE50311184D1 (de) EG-VEGF/Prokineticin 2 Rezeptor Antagonisten
UA30315A (uk) Спосіб діагностики захворювань органів малого таза